Skip to content

Effect of Aromatherapy on Venopuncture Pain and Anxiety

Evaluation of the Effect of Aromatherapy With Lavender Essential Oil on Pain and Anxiety During Peripheral Venous Cannulation

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02592044
Enrollment
106
Registered
2015-10-30
Start date
2015-11-30
Completion date
2016-03-31
Last updated
2016-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

pain, anxiety, Catheterization, Peripheral

Brief summary

The effect of aromatherapy with lavender essential oil on pain and anxiety during venipuncture will be evaluated.

Detailed description

The anxiety and pain during venipuncture may be cause to the avoidance of the medical therapy in patient as well as adult. Aromatherapy with lavender was shown that beneficial effects on chronic pain and anxiety. It's effect on acute pain and anxiety is not exactly known. In this study, the aromatherapy with the lavender will be compared with placebo to evaluate the analgesic and anxiolytic effect during peripheral venous cannulation before surgery.

Interventions

The 18 gauge venous cannula will be inserted in a peripheral vein on the back of right hand of the patient.

PROCEDUREAromatherapy with lavender essential oil

The two drops of lavender essential oil will be dropped into the gauze and the patient will inhale it for 5 minutes and during venous cannulation.

PROCEDUREPlacebo

The two drops of water will be dropped into the gauze and the patient will inhale it for 5 minutes and during venous cannulation.

Sponsors

Tokat Gaziosmanpasa University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* be scheduled for elective surgery * be accepted to inhale lavender

Exclusion criteria

* age \<18 years \>65 years * preoperative pain or consumption of analgesic medication * anxiety disorders or consumption of anxiolytic medications (i.e. SSRI, benzodiazepine) * pregnancy or breastfeeding * asthma, chronic obstructive pulmonary disease * poor sense of smell * allergy to the lavender essential oil

Design outcomes

Primary

MeasureTime frameDescription
Pain LevelWithin the first 5 minutes after the peripheral venous cannula insertion processThe pain of the patients during cannulation will be measured with Visual Analog Scale from 0 to 10.

Secondary

MeasureTime frameDescription
Anxiety LevelWithin the first 5 minutes after the peripheral venous cannula insertion processThe anxiety of the patient during cannulation will be measured with Visual Analog Scale from 0 to 10.
Patient SatisfactionWithin the first 15 minutes after the peripheral venous cannula insertion processThe patients' satisfaction will be measured with 5-point likert scale with 0 to 4.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026